Application 091117
- Type
- ANDA
- Sponsor
- ASTRAL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CEFTRIAXONE SODIUM | CEFTRIAXONE SODIUM | INJECTABLE;INJECTION | EQ 10GM BASE/VIAL | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 66794-215 | Ceftriaxone | Ceftriaxone | Piramal Critical Care Inc | ANDA | Current |
| 66794-215 | Ceftriaxone | Ceftriaxone | Piramal Critical Care Inc | ANDA | Current |
| 66794-215 | Ceftriaxone | Ceftriaxone | Piramal Critical Care Inc | ANDA | Current |
| 66794-215 | Ceftriaxone | Ceftriaxone | Piramal Critical Care Inc | ANDA | Current |
| 66794-215 | Ceftriaxone | Ceftriaxone | Piramal Critical Care Inc | ANDA | Current |
| 66794-215 | Ceftriaxone | Ceftriaxone | Piramal Critical Care Inc | ANDA | Current |
| 70594-098 | Ceftriaxone | Ceftriaxone | Xellia Pharmaceuticals USA LLC | ANDA | Current |